KORU Medical Systems Inc (KRMD)

Currency in USD
3.250
+0.030(+0.93%)
Closed·
3.2500.000(0.00%)
·
Advertisement
KRMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.1603.300
52 wk Range
3.1406.608
Key Statistics
Prev. Close
3.22
Open
3.22
Day's Range
3.16-3.3
52 wk Range
3.14-6.608
Volume
116.64K
Average Volume (3m)
192.87K
1-Year Change
-19.9507%
Book Value / Share
0.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KRMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.250
Upside
+92.31%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

KORU Medical Systems Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.250
(+92.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy8.00+146.15%7.00Maintain13/03/2026
Piper Sandler
Hold5.00+53.85%4.00Maintain20/01/2026
Craig-Hallum
Buy7.00+115.38%6.25Maintain13/01/2026
Lake Street Capital Markets
Buy8.00+146.15%6.00Maintain22/12/2025
Canaccord Genuity
Buy6.00+84.62%5.00Maintain17/12/2025

KORU Medical Systems Inc Earnings Call Summary for Q2/2026

  • KORU Medical posted Q2 2026 revenue of $12M (up 18% YoY), beating estimates of $11.62M, but shares fell 7.51% after hours on lowered guidance.
  • Company reported first positive net income since 2019; gross margin improved to 65.1% from 63.5%, with adjusted EBITDA of $900K in H1 2026.
  • Full-year 2026 revenue guidance narrowed to $47.5M-$48.5M, below prior outlook, citing slower international market timing in non-tender regions.
  • International core revenue surged 59% to $3.5M while domestic core grew 12% to $8M; Pharma Services revenue fell 35% on lower clinical trial orders.
  • CEO emphasized digital transformation strategy; company expects year-end cash above $7.5M and raised gross margin guidance to 62%-64% from 61%-63%.
Last Updated: 05/08/2026, 22:26
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
0.02 / -0.02
Revenue / Forecast
12M / 11.62M
EPS Revisions
Last 90 days

Compare KRMD to Peers and Sector

Metrics to compare
KRMD
Peers
Sector
Relationship
P/E Ratio
−82.5x−2.0x−0.4x
PEG Ratio
−1.39−0.170.00
Price/Book
8.3x3.2x2.6x
Price / LTM Sales
3.3x2.3x3.0x
Upside (Analyst Target)
84.6%35.9%48.7%
Fair Value Upside
Unlock5.9%7.0%Unlock

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.96M12.91%19.37M
Other Institutional Investors
28.81M62.39%93.63M
Public Companies & Retail Investors
11.40M24.70%37.06M
Total
46.17M100.00%150.06M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Horton Capital Partners Fund, L.P.10.98%5,069,54116,476
Horton Capital Management, LLC10.98%5,069,54116,476

People Also Watch

2.87
SITC
0.00%
6.13
LZ
-4.22%
49.860
LMB
+0.63%
171.61
BCPC
-0.08%
72.43
JBSS
-1.02%

FAQ

What Is the KORU Medical Systems (NASDAQ: KRMD) Share Price Today?

The KORU Medical Systems stock price today is 3.250 USD.

What Stock Exchange Does KORU Medical Systems (KRMD) Trade On?

KORU Medical Systems is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for KORU Medical Systems?

The stock symbol (also called a 'ticker') for KORU Medical Systems is "KRMD."

What Is the Current KORU Medical Systems Market Capitalisation?

As of today, KORU Medical Systems (NASDAQ: KRMD) market cap is 148.670M USD.

What Is KORU Medical Systems's (KRMD) Earnings Per Share (TTM)?

The KORU Medical Systems EPS is currently -0.040 (Trailing Twelve Months).

When Is the Next KORU Medical Systems Earnings Date?

KORU Medical Systems's next earnings report will be released on 11/11/2026.

Is KRMD a Buy or Sell From a Technical Analyst Perspective?

Based on today's KORU Medical Systems moving averages and other technical indicators, the daily buy/sell signal for KRMD stock is Strong Sell.

How Many Times Has KORU Medical Systems Stock Split?

KORU Medical Systems has split 0 times. (See the KRMD stock split history page for full effective split date and price information.)

How Many Employees Does KORU Medical Systems Have?

KORU Medical Systems has 73 employees, based on their latest Companies House report.

What is the current trading status of KORU Medical Systems (NASDAQ: KRMD)?

As of 05/09/2026, KORU Medical Systems (KRMD) is trading at a share price of 3.250 USD, with a previous close of 3.220 USD. The stock has fluctuated within a day range of 3.160 USD to 3.300 USD, while its 52-week range spans from 3.140 USD to 6.608 USD.

What Is KORU Medical Systems (KRMD) Price Target According to Analysts?

The average 12-month price target for KORU Medical Systems is 6.250 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +92.31% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.